戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 strative aspects of care (e.g., gatekeeping, utilization review).
2 e legislative mandate for retrospective drug utilization review.
3 tions in the California Controlled Substance Utilization Review and Evaluation System (CURES) databas
4  2021 from California's Controlled Substance Utilization Review and Evaluation System (CURES).
5                                              Utilization review and structural arrangements in manage
6 ve benefits while restricting access through utilization review, has infuriated everyone involved.
7 xceptions coincident with retrospective drug utilization review implementation (rate increase, 0.064
8 examined as a function of retrospective drug utilization review implementation.
9                           Retrospective drug utilization review is required of all state Medicaid pro
10 e also found no effect of retrospective drug utilization review on the incidence of all-cause hospita
11  to identify an effect of retrospective drug utilization review on the rate of exceptions or on clini
12                                  Health plan utilization review rules are intended to enforce insuran
13 ehavior of physicians through capitation and utilization review, the major health plans now seek to i
14                                              Utilization review (UR) seeks to improve quality and cos